Top-News
Biotechnologie USA

Novavax News

Aktie
WKN:  A2PKMZ ISIN:  US6700024010 US-Symbol:  NVAX
11,998 €
+0,182 €
+1,54%
12:50:54 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
100,90 Mio.
Marktkapitalisierung *
1,19 Mrd. €
Streubesitz
37,03%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 07.11.2023

Ad-hocs

07.11.17 - GlobeNewswire
Novavax Reports Third Quarter 2017 Financial Results
Novavax Reports Third Quarter 2017 Financial Results GAITHERSBURG, Md., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced its financial ...
27.02.17 - GlobeNewswire
Novavax Reports Fourth Quarter and Year-End 2016 Financial Results
Novavax Reports Fourth Quarter and Year-End 2016 Financial Results GAITHERSBURG, Md., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced ...
20.02.17 - GlobeNewswire
Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017
Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017 GAITHERSBURG, Md., Feb. 20, 2017 (GLOBE NEWSWIRE) -...
06.12.16 - GlobeNewswire
Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference
Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference GAITHERSBURG, Md., 2016-12-06 22:05 CET (GLOBE NEWSWIRE) -- Novavax, Inc., ...
22.10.15 - GlobeNewswire
Novavax Initiates Phase 2 Safety and Immunogenicity Trial to Evaluate Annual Re-Dosing of the RSV F Vaccine in Older Adults
Novavax Initiates Phase 2 Safety and Immunogenicity Trial to Evaluate Annual Re-Dosing of the RSV F Vaccine in Older Adults GAITHERSBURG, Md., Oct. 22, 2015 (GLOBE ...
10.09.15 - GlobeNewswire
Novavax RSV F Vaccine Clinical Trial Data in Women of Child Bearing Age Published in the Journal of Infectious Disease
Novavax RSV F Vaccine Clinical Trial Data in Women of Child Bearing Age Published in the Journal of Infectious Disease GAITHERSBURG, Md., Sept. 10, 2015 (GLOBE ...
08.01.15 - GlobeNewswire
Novavax Announces Management Promotion
Novavax Announces Management Promotion Novavax, Inc. (Nasdaq:NVAX) today announced that Jill Hoyt has been named Vice President, Human Resources & Administration. Ms. ...

Newssuche

Videos

newspaper
27.06.24 -3,89%
Technical Trading: 10yr T-Notes Long Chance
10yr T-Notes Long Typ: Turbo Open End WKN: JL04UJ Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »